DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Khaykin Y, Wang X, Natale A, Wazni OM, Skanes AC, Humphries KH, Kerr CR, Verma A, Morillo CA.
Cost comparison of ablation versus
antiarrhythmic drugs as first-line therapy for atrial fibrillation:
an economic evaluation of the RAAFT pilot study.
J Cardiovasc
Electrophysiol 2009; 20: 7-12
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.